← Back to headlines
TG Therapeutics Secures $750M Credit Facility, Boosts Buyback to $300M
TG Therapeutics has successfully secured a $750 million credit facility with Blue Owl and simultaneously announced an increase in its share buyback program to $300 million.
19 Mar, 11:38 — 19 Mar, 11:38
Sources
Showing 1 of 1 sources
Related Stories
Lithuanian Minister Defines Pension Pillars: State for First, Business for Second
7m ago
Homeowners are kept on the rack - Trump's war in Iran could lead to interest rate hikes
8m ago
Evolve Enhanced Yield Bond Fund ETFs Declare CAD 0.19 Dividend
15m ago
EU Court Considers Extending Statute of Limitations for Polish Swiss Franc Mortgage Holders
16m ago